1. DIGITAL.CSIC

Martínez Gil, Ana

Colaboraciones Ver estadísticas de uso Alertas por Email RSS

Perfil

ft_6859ana.jpg picture
 
Firma en Digital.CSIC (*)
Martínez Gil, Ana
 
Centro o Instituto
CSIC - Centro de Investigaciones Biológicas (CIB)
 
Departamento
Biología Físico-química
 
Especialización
Química Médica y Biológica traslacional
 
Email
ana.martinez@csic.es
 
ORCID
 
WoS ResearcherID - Publons
 
Scopus AuthorID
 

Publications

Refined By:
Palabras Clave:  Neurodegeneration

Resultados 1-6 de 6.

DerechosPreviewFecha Public.TítuloAutor(es)Tipo
1openAccess1 Benzo d thiazol 2 yl 3 phenylureas as dual inhibitors of casein kinase 1 and ABAD enzymes for treatment of neurodegenerative disorders.pdf.jpg14-mar-20181-(Benzo[d]thiazol-2-yl)-3-phenylureas as dual inhibitors of casein kinase 1 and ABAD enzymes for treatment of neurodegenerative disordersBenek, O.; Pérez, Daniel I. CSIC ORCID; Pérez, Concepción CSIC ORCID; Martínez Gil, Ana CSIC ORCID ; Musilek, Kamilartículo
2openAccessCognitive_Isabel_Preprint_2020.pdf.jpgdic-2020Cognitive enhancement, TAU phosphorylation reduction, and neuronal protection by the treatment of an LRRK2 inhibitor in a tauopathy mouse modelCastro-Sánchez, Sara CSIC ORCID; Zaldívar-Díez, Josefa CSIC ORCID; Luengo, Enrique; López, Manuela G.; Gil, Carmen CSIC ORCID ; Martínez Gil, Ana CSIC ORCID ; Lastres-Becker, Isabel CSIC ORCIDartículo
3openAccessTranslational Stroke Research_Atienza-Navarro_2024.pdf.jpg17-ene-2024Glycogen synthase kinase‑3β inhibitor VP3.15 ameliorates neurogenesis, neuronal loss and cognitive impairment in a model of germinal matrix‑intraventricular hemorrhage of the preterm newbornAtienza-Navarro, Isabel; Marco, Ángel del; Alves-Martínez, Pilar; Garcia‑Perez, Maria de los Angeles; Raya‑Marin, Alvaro; Benavente-Fernandez, Isabel; Gil, Carmen CSIC ORCID ; Martínez Gil, Ana CSIC ORCID ; Lubián-López, Simón P.; García-Alloza, Mónicaartículo
4openAccessJournal of Enzyme Inhibition and Medicinal Chemistry_Maestro_2023.pdf.jpg13-ene-2023Identification of a new structural family of SGK1 inhibitors as potential neuroprotective agentsMaestro, Inés CSIC ORCID; Madruga, Enrique CSIC ORCID; Boya, Patricia CSIC ORCID ; Martínez Gil, Ana CSIC ORCID artículo
5openAccessNew Statement about NRF2_Lastres_PV_Art2022.pdf.jpg2022New statement about NRF2 in amyotrophic lateral sclerosis and frontotemporal dementiaLastres-Becker, Isabel CSIC ORCID; Lago, Eva de; Martínez Gil, Ana CSIC ORCID ; Fernández-Ruiz, Javierartículo
6openAccess14-jul-2020Novel Curcumin-Diethyl Fumarate Hybrid as a dualistic GSK-3β inhibitor/Nrf2 inducer for the treatment of Parkinson’s diseaseDi Martino, Rita Maria Concetta; Pruccoli, Letizia; Bisi, Alessandra; Gobbi, Silvia; Rampa, Angela; Martínez Gil, Ana CSIC ORCID ; Pérez, Concepción CSIC ORCID; Martínez-González, Loreto CSIC ORCID ; Paglione, Maria; Di Schiavi, Elia; Seghetti, Francesca; Tarozzi, Andrea; Belluti, Federicaartículo